The objective of this Contract is the development and manufacture of oral dosage forms of drugs which will be used for human clinical trials carried out under the auspices of the National Cancer Institute. Those drugs will usually consist of anti-cancer and anti-AIDS compounds. Dosage forms will include but not be limited to tablets, enteric coated tablets, capsules, soft gelatin capsules, encapsulated granules and oral powders and solutions. The contractor shall test the products from experimental and manufacturing runs for strength, identity and performance characteristics. Facilities, equipment and procedures shall conform to FDA prescribed Current Good Manufacturing Practices (CGMP).

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM047014-013
Application #
6193317
Study Section
Project Start
1994-09-30
Project End
1999-11-30
Budget Start
1999-03-17
Budget End
1999-11-30
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Iowa
Department
Miscellaneous
Type
Schools of Pharmacy
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242